Document is current
Any future updates will be listed below
-
Authors
Wu, Xueji https://orcid.org/0000-0003-4947-7849
Xie, Wei https://orcid.org/0000-0002-7636-1051
Xie, Wenxuan
Wei, Wenyi https://orcid.org/0000-0003-0512-3811
Guo, Jianping https://orcid.org/0000-0002-8158-0101
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32070767)
- License Information
-
More Information
Article History
Received: 6 April 2022
Revised: 5 July 2022
Accepted: 7 July 2022
First Online: 25 July 2022
Competing interests
: WW is a co-founder and consultant for the ReKindle Therapeutics. Other authors declare no competing interests.
